Sheikh Shakhbout Medical City Introduces Swallowable Diagnostic Capsule
Sheikh Shakhbout Medical City has introduced PillSense, a swallowable diagnostic capsule that detects upper gastrointestinal bleeding in under 10 minutes. The innovative... Read more.
ADCAN Pharma, Menarini Partner to Boost UAE Pharmaceutical Manufacturing
ADCAN Pharma and Menarini have partnered to manufacture selected pharmaceutical products in the UAE, strengthening local production capabilities, improving medicine... Read more.
Aster DM Healthcare acquires ProCare Hospital in Saudi Arabia, expanding to 500+ beds in the Kingdom
Aster DM Healthcare has acquired a majority stake in ProCare Hospital in Saudi Arabia's Eastern Province, expanding its presence beyond Riyadh. The move increases... Read more.
Vertex Presents New CASGEVY Data in Children, Expands Global Regulatory Filings
Vertex Pharmaceuticals presented new data showing positive outcomes with CASGEVY in children aged 5–11 with sickle cell disease or beta thalassemia and announced... Read more.
Orionis Biosciences Announces Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines
Orionis Biosciences and Novartis have expanded their strategic collaboration to discover and develop molecular glue medicines, leveraging Orionis’s AI-driven Allo-Glue... Read more.
UAE Approves New Oral Breast Cancer Treatment for Hormone-Resistant Cases
The UAE has approved AstraZeneca’s Etcamah, a new oral therapy for advanced breast cancer patients with ESR1 mutations, expanding treatment options for hormone-resistant... Read more.
PRCA MENA Launches 4th Annual Mental Health Survey
PRCA MENA has launched the fourth edition of its regional Mental Health Survey, inviting communications professionals across the Middle East and North Africa to... Read more.
LCRF and AstraZeneca Launch Research Awards to Advance Small Cell Lung Cancer Treatment
The Lung Cancer Research Foundation (LCRF), in collaboration with AstraZeneca, has announced two new research funding opportunities aimed at improving outcomes for... Read more.
IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy
IBA has entered into a sponsored research agreement with The University of Texas MD Anderson Cancer Center to generate clinical and economic evidence supporting... Read more.
Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy
Sanofi has announced the discontinuation of its Phase 3 MOBILIZE study evaluating riliprubart in patients with chronic inflammatory demyelinating polyneuropathy... Read more.
